http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2019003172-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
filingDate 2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc953c1b3228a3c770197cb216618e73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6157469ac73eb30627c60e572ea18971
publicationDate 2020-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2019003172-A1
titleOfInvention Brimonidine intended for the use and design of clinical trials for geographic atrophy due to age-related macular degeneration.
abstract METHODS TO TREAT OR SLOW THE GROWTH OF AN INJURY ASSOCIATED WITH GEOGRAPHICAL ATROPHY AND METHODS TO EVALUATE A DRUG (BRIMONIDINE) OR AGENT FOR USE IN THE TREATMENT, REDUCTION OF THE EVOLUTION OR THE SLOWDOWN OF ATROPHY GROWTH GEOGRAPHIC.
priorityDate 2017-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414161244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2435

Total number of triples: 25.